Seeking modifier genes in cystic fibrosis

American Journal of Respiratory and Critical Care Medicine

Volumn 167, Issue 3, 2003, Pages 289-290

  Accurso, Frank J ^a   Sontag, Marci K ^a  

^a Children's Hospital Colorado   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; NITRIC OXIDE SYNTHASE; TRANSFORMING GROWTH FACTOR; TRYPSIN INHIBITOR; TUMOR NECROSIS FACTOR;

CHROMOSOME 19; CYSTIC FIBROSIS; DISEASE COURSE; DNA POLYMORPHISM; EDITORIAL; GENE IDENTIFICATION; GENE LOCUS; GENE MUTATION; GENETIC CODE; GENETIC EPIDEMIOLOGY; GENOTYPE; HEREDITY; HOST RESISTANCE; HUMAN; LUNG DISEASE; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEX DIFFERENCE;

CYSTIC FIBROSIS; HUMANS; NITRIC OXIDE; PEPTIDYL-DIPEPTIDASE A;

EID: 0037321827     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.2210006     Document Type: Editorial

References (11)

1. Cystic Fibrosis Foundation. Patient registry 2001: annual report. Bethesda, MD: Cystic Fibrosis Foundation; 2002.
2. Kerem E, Corey M, Kerem BS, Rommens J, Markiewicz D, Levison H, Tsui LC, Durie P. The relation between genotype and phenotype in cystic fibrosis-analysis of the most common mutation (delta F508). N Engl J Med 1990;323:1517-1522.
3. Zielenski J, Corey M, Rozmahel R, Markiewicz D, Aznarez I, Casals T, Larriba S, Mercier B, Cutting GR, Krebsova A, et al. Detection of a cystic fibrosis modifier locus for meconium ileus on human chromosome 19q13. Nat Genet 1999;22:128-129.
4. Hull J, Thomson AH. Contribution of genetic factors other than CFTR to disease severity in cystic fibrosis. Thorax 1998;53:1018-1021.
5. Drumm ML. Modifier genes and variation in cystic fibrosis. Respir Res 2001;2:125-128.
6. Grasemann H, Storm van's Gravesande K, Büscher R, Knauer N, Silverman ES, Palmer LJ, Drazen JM, Ratjen F. Endothelial nitric oxide synthase variants in cystic fibrosis lung disease. Am J Respir Crit Care Med 2003;167:390-394.
7. Kelley TJ, Drumm ML. Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells. J Clin Invest 1998;102:1200-1207.
8. Grasemann H, Knauer N, Buscher R, Hubner J, Drazen M, Ratjen F. Airway nitric oxide levels in cystic fibrosis patients are related to a polymorphism in the neuronal nitric oxide synthase gene. Am J Respir Crit Care Med 2000;162:2172-2176.
9. Arkwright PD, Pravica V, Geraghty PJ, Super M, Webb AK, Schwarz M, Hutchinson IV. End-organ dysfunction in cystic fibrosis: association with angiotensin I converting enzyme and cytokine gene polymorphisms. Am J Respir Crit Care Med 2003:167:384-389.
10. Moffatt MF, Schou C, Faux JA, Abecasis GR, James A, Musk AW, Cookson WO. Association between quantitative traits underlying asthma and the HLA- DRB1 locus in a family-based population sample. Eur J Hum Genet 2001;9:341-346.
11. Bronsveld I, Mekus F, Bijman J, Ballmann M, de Jonge HR, Laabs U, Halley DJ, Ellemunter H, Mastella G, Thomas S, et al. Chloride conductance and genetic background modulate the cystic fibrosis phenotype of Delta F508 homozygous twins and siblings. J Clin Invest 2001;108:1705-1715.